DRKS00021523CompletedNot Applicable
The influence of proton pump inhibitor therapy on the clinical course of COVID-19 - COVID.PPI
niversitätsklinikum Freiburg, Klinik für Innere Medizin II0 sites152 target enrollmentStarted: April 27, 2020Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 152
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Observational
Eligibility Criteria
- Ages
- 18 Years to one (—)
- Sex
- All
Inclusion Criteria
- •Confirmed SARS-CoV2- infection, hospitalized patients
Exclusion Criteria
- •SARS-CoV2 infection excluded, outpatient treatment
Investigators
Similar Trials
Not yet recruiting
Not Applicable
A study on the effect of proton pump inhibitors on the intragastric pH for the patients of functional dysplasiaFunctional dyspepsia(FD)JPRN-UMIN000003127FD-pH Society60
Completed
Not Applicable
Effect of stopping proton pump inhibitors (PPI) on the incidence of Clostridium difficile diarrhoea (CDD)Digestive System: DiarrhoeaDigestive SystemDiarrhoeaISRCTN04808359Record Provided by the NHSTCT Register - 2004 Update - Department of Health (UK)400
Not yet recruiting
Not Applicable
Study of the effect of Proton Pump Inhibitor (PPI) on intra-gastric pH in healthy volunteer - Comparison of Esomeprazole and RabeprazoleGastroesophageal reflux disease(GERD)JPRN-UMIN000014577Shimane University Faculty of Medicine Second Department of Internal Medicine30
Not yet recruiting
Not Applicable
Study of the effect of Proton Pump Inhibitor (PPI) on intra-gastric pH in healthy volunteer - Comparison of Esomeprazole and RabeprazoleGastroesophageal Reflux Disease(GERD)JPRN-UMIN000006319Shimane University Faculty of Medicine, Department of Gastroenterology and Hepatology24
Unknown
Not Applicable
Research on the effect of a proton pump inhibitor on the oral and intestinal microbiota and salivary protein and metabolites.healthy volunteerJPRN-UMIN000025331Shimane university24